MetaADEDB 2.0 @ LMMD
acetaminophen, aspirin, caffeine drug combination
(BKMBGNWZSQNIKU-UHFFFAOYSA-N)
Structure
SMILES
Cn1cnc2c1c(=O)n(C)c(=O)n2C.CC(=O)Oc1ccccc1C(=O)O.CC(=O)Nc1ccc(cc1)O
Molecular Formula:
C25H27N5O8
Molecular Weight:
525.511
Log P:
1.7044
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
3
TPSA:
174.75
CAS Number(s):
83535-74-4
Synonym(s)
1.
acetaminophen, aspirin, caffeine drug combination
2.
CKT analgesic powder
3.
Chap Kaki Tiga
4.
Dikalm
5.
Excedrin extra strength
6.
acetaminophen - aspirin - caffeine
External Link(s)
MeSHC110820
PubChem Compound9871508
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 557US FAERS
2NauseaFAERS: 169US FAERS
3Drug DependenceFAERS: 152US FAERS
4Incorrect drug administration durationFAERS: 150US FAERS
5OverdoseFAERS: 125US FAERS
6DizzinessFAERS: 120US FAERS
7HeadacheFAERS: 115US FAERS
8VomitingFAERS: 102US FAERS
9Medication ErrorFAERS: 94US FAERS
10Feeling abnormalFAERS: 86US FAERS
11Incorrect dose administeredFAERS: 79US FAERS
12MalaiseFAERS: 70US FAERS
13DyspepsiaFAERS: 65US FAERS
14PainFAERS: 55US FAERS
15TremorFAERS: 46US FAERS
16Intentional drug misuseFAERS: 45US FAERS
17Therapeutic response unexpectedFAERS: 44US FAERS
18HypersensitivityFAERS: 42US FAERS
19NervousnessFAERS: 38US FAERS
20Chest PainFAERS: 35US FAERS
21UlcerFAERS: 35US FAERS
22ArthritisFAERS: 34US FAERS
23Wrong technique in drug usage processFAERS: 32US FAERS
24UrticariaFAERS: 31US FAERS
25Back PainFAERS: 30US FAERS
26PalpitationsFAERS: 30US FAERS
27Gastric ulcerFAERS: 29US FAERS
28Feeling jitteryFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Drug abuserFAERS: 25US FAERS
30Diabetes MellitusFAERS: 24US FAERS
31Product quality issueFAERS: 24US FAERS
32Abdominal discomfortFAERS: 23US FAERS
33AstheniaFAERS: 23US FAERS
34SomnolenceFAERS: 23US FAERS
35Disease recurrenceFAERS: 22US FAERS
36Myocardial InfarctionFAERS: 22US FAERS
37Inappropriate schedule of drug administrationFAERS: 21US FAERS
38TinnitusFAERS: 21US FAERS
39Abdominal PainFAERS: 20US FAERS
40Cerebrovascular accidentFAERS: 20US FAERS
41FatigueFAERS: 20US FAERS
42AsthmaFAERS: 19US FAERS
43EpistaxisFAERS: 19US FAERS
44Lip swellingFAERS: 19US FAERS
45Accidental exposureFAERS: 18US FAERS
46PruritusFAERS: 18US FAERS
47AnxietyFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
48Expired drug administeredFAERS: 15US FAERS
49PneumoniaFAERS: 15US FAERS
50Throat irritationFAERS: 15US FAERS
51Weight decreasedFAERS: 15US FAERS
52ArthralgiaFAERS: 14US FAERS
53ErythemaFAERS: 14US FAERS
54Rebound effectFAERS: 14US FAERS
55Blood cholesterol increasedFAERS: 13US FAERS
56DeafnessFAERS: 13US FAERS
57DependenceFAERS: 13US FAERS
58Foreign body traumaFAERS: 13US FAERS
59GastritisFAERS: 12US FAERS
60PregnancyFAERS: 12US FAERS
61Chest discomfortFAERS: 11US FAERS
62ChillsFAERS: 11US FAERS
63DisorientationFAERS: 11US FAERS
64FibromyalgiaFAERS: 11US FAERS
65InfectionFAERS: 11US FAERS
66AbasiaFAERS: 10US FAERS
67AmnesiaFAERS: 10US FAERS
68NephrolithiasisFAERS: 10US FAERS
69RetchingFAERS: 10US FAERS
70SwellingFAERS: 10US FAERS
71Unevaluable eventFAERS: 10US FAERS
72Drug ineffective for unapproved indicationFAERS: 9US FAERS
73GlaucomaFAERS: 9US FAERS
74Multiple SclerosisFAERS: 9US FAERS
75Muscle tightnessFAERS: 9US FAERS
76Musculoskeletal PainFAERS: 9US FAERS
77Neck PainFAERS: 9US FAERS
78Urinary tract infectionFAERS: 9US FAERS
79Euphoric moodFAERS: 8US FAERS
80FlatulenceFAERS: 8US FAERS
81Memory impairmentFAERS: 8US FAERS
82SyncopeFAERS: 8US FAERS
83Accidental overdoseFAERS: 7US FAERS
84Anaphylactic shockFAERS: 7US FAERS
85Atrial FibrillationFAERS: 7US FAERS
86CataractFAERS: 7US FAERS
87DysgeusiaFAERS: 7US FAERS
88Musculoskeletal stiffnessFAERS: 7US FAERS
89Pharyngolaryngeal PainFAERS: 7US FAERS
90VertigoFAERS: 7US FAERS
91Wrong technique in product usage processFAERS: 7US FAERS
92Accidental drug intake by childFAERS: 6US FAERS
93BlindnessFAERS: 6US FAERS
94Concomitant disease aggravatedFAERS: 6US FAERS
95ConstipationFAERS: 6US FAERS
96Drug exposure during pregnancyFAERS: 6US FAERS
97Initial insomniaFAERS: 6US FAERS
98Maternal exposure during pregnancyFAERS: 6US FAERS
99OsteoporosisFAERS: 6US FAERS
100Product use issueFAERS: 6US FAERS
101RestlessnessFAERS: 6US FAERS
102SciaticaFAERS: 6US FAERS
103Spinal column stenosisFAERS: 6US FAERS
104Activities of daily living impairedFAERS: 5US FAERS
105Blood glucose increasedFAERS: 5US FAERS
106BronchitisFAERS: 5US FAERS
107Burning sensationFAERS: 5US FAERS
108ChokingFAERS: 5US FAERS
109Cold sweatFAERS: 5US FAERS
110CryingFAERS: 5US FAERS
111DiplopiaFAERS: 5US FAERS
112Drug abuseFAERS: 5US FAERS
113EpilepsyFAERS: 5US FAERS
114Foaming at mouthFAERS: 5US FAERS
115GoutFAERS: 5US FAERS
116Head discomfortFAERS: 5US FAERS
117HungerFAERS: 5US FAERS
118Middle insomniaFAERS: 5US FAERS
119Oropharyngeal painFAERS: 5US FAERS
120PallorFAERS: 5US FAERS
121Poor quality sleepFAERS: 5US FAERS
122Rheumatoid ArthritisFAERS: 5US FAERS
123SinusitisFAERS: 5US FAERS
124StomatitisFAERS: 5US FAERS
125StressFAERS: 5US FAERS
126ThrombosisFAERS: 5US FAERS
127Visual ImpairmentFAERS: 5US FAERS
128AphasiaFAERS: 4US FAERS
129ArthropathyFAERS: 4US FAERS
130Cardiac FlutterFAERS: 4US FAERS
131CholelithiasisFAERS: 4US FAERS
132Electrocardiogram abnormalFAERS: 4US FAERS
133Feeling ColdFAERS: 4US FAERS
134FlushingFAERS: 4US FAERS
135FrustrationFAERS: 4US FAERS
136HerniaFAERS: 4US FAERS
137HypotensionFAERS: 4US FAERS
138Intentional misuseFAERS: 4US FAERS
139Intracranial AneurysmFAERS: 4US FAERS
140Joint swellingFAERS: 4US FAERS
141LethargyFAERS: 4US FAERS
142Mental impairmentFAERS: 4US FAERS
143PapuleFAERS: 4US FAERS
144PharyngitisFAERS: 4US FAERS
145Product use in unapproved indicationFAERS: 4US FAERS
146Wheelchair userFAERS: 4US FAERS
147WheezingFAERS: 4US FAERS
148nervous system disorderFAERS: 4US FAERS
149Adverse eventFAERS: 3US FAERS
150BedriddenFAERS: 3US FAERS
151CandidiasisFAERS: 3US FAERS
152Cardiac ArrestFAERS: 3US FAERS
153CardiomegalyFAERS: 3US FAERS
154DehydrationFAERS: 3US FAERS
155Depressed moodFAERS: 3US FAERS
156DisabilityFAERS: 3US FAERS
157Drug screen positiveFAERS: 3US FAERS
158Drug withdrawal syndromeFAERS: 3US FAERS
159DysuriaFAERS: 3US FAERS
160HemiparesisFAERS: 3US FAERS
161HypokinesiaFAERS: 3US FAERS
162Impaired work abilityFAERS: 3US FAERS
163Irritable Bowel SyndromeFAERS: 3US FAERS
164Joint injuryFAERS: 3US FAERS
165MenorrhagiaFAERS: 3US FAERS
166Muscle strainFAERS: 3US FAERS
167NasopharyngitisFAERS: 3US FAERS
168Nerve injuryFAERS: 3US FAERS
169No adverse eventFAERS: 3US FAERS
170Opiates positiveFAERS: 3US FAERS
171PancreatitisFAERS: 3US FAERS
172Pharmaceutical product complaintFAERS: 3US FAERS
173Post-traumatic neck syndromeFAERS: 3US FAERS
174Renal painFAERS: 3US FAERS
175Respiratory arrestFAERS: 3US FAERS
176Sinus headacheFAERS: 3US FAERS
177Suicide attemptFAERS: 3US FAERS
178Therapeutic response changedFAERS: 3US FAERS
179ToothacheFAERS: 3US FAERS
180Walking aid userFAERS: 3US FAERS
181AgitationFAERS: 2US FAERS
182AneurysmFAERS: 2US FAERS
183AngioedemaFAERS: 2US FAERS
184AphoniaFAERS: 2US FAERS
185ArteriosclerosisFAERS: 2US FAERS
186Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
187Back disorderFAERS: 2US FAERS
188Bladder prolapseFAERS: 2US FAERS
189BlepharospasmFAERS: 2US FAERS
190Blood cholesterol abnormalFAERS: 2US FAERS
191Blood potassium decreasedFAERS: 2US FAERS
192Cancer PainFAERS: 2US FAERS
193CellulitisFAERS: 2US FAERS
194Cervix carcinomaFAERS: 2US FAERS
195Choking sensationFAERS: 2US FAERS
196Cholecystitis infectiveFAERS: 2US FAERS
197ChromaturiaFAERS: 2US FAERS
198Compression fractureFAERS: 2US FAERS
199CystoceleFAERS: 2US FAERS
200Depressed Level of ConsciousnessFAERS: 2US FAERS
201DermatomyositisFAERS: 2US FAERS
202DiscomfortFAERS: 2US FAERS
203DiverticulumFAERS: 2US FAERS
204Drug toxicityFAERS: 2US FAERS
205Drug withdrawal headacheFAERS: 2US FAERS
206Duodenal UlcerFAERS: 2US FAERS
207DysphoniaFAERS: 2US FAERS
208Emotional distressFAERS: 2US FAERS
209Eye painFAERS: 2US FAERS
210Failure of child resistant mechanism for pharmaceutical productFAERS: 2US FAERS
211Gastric pH decreasedFAERS: 2US FAERS
212HyperthyroidismFAERS: 2US FAERS
213HysterectomyFAERS: 2US FAERS
214Idiopathic urticariaFAERS: 2US FAERS
215Incorrect route of drug administrationFAERS: 2US FAERS
216Increased upper airway secretionFAERS: 2US FAERS
217InfestationFAERS: 2US FAERS
218InfluenzaFAERS: 2US FAERS
219Intervertebral Disc DegenerationFAERS: 2US FAERS
220Intervertebral disc disorderFAERS: 2US FAERS
221LabyrinthitisFAERS: 2US FAERS
222LaryngospasmFAERS: 2US FAERS
223Limb discomfortFAERS: 2US FAERS
224LymphadenopathyFAERS: 2US FAERS
225LymphomaFAERS: 2US FAERS
226Macular degenerationFAERS: 2US FAERS
227Medication overuse headacheFAERS: 2US FAERS
228MeningitisFAERS: 2US FAERS
229Meniscus injuryFAERS: 2US FAERS
230Mood swingsFAERS: 2US FAERS
231Multiple MyelomaFAERS: 2US FAERS
232MyalgiaFAERS: 2US FAERS
233MydriasisFAERS: 2US FAERS
234Oral painFAERS: 2US FAERS
235OsteopeniaFAERS: 2US FAERS
236Pericardial effusionFAERS: 2US FAERS
237Poor quality drug administeredFAERS: 2US FAERS
238Post procedural complicationFAERS: 2US FAERS
239PresyncopeFAERS: 2US FAERS
240Product comminglingFAERS: 2US FAERS
241Product formulation issueFAERS: 2US FAERS
242Product packaging quantity issueFAERS: 2US FAERS
243Product tamperingFAERS: 2US FAERS
244SarcoidosisFAERS: 2US FAERS
245SclerodermaFAERS: 2US FAERS
246Seizure like phenomenaFAERS: 2US FAERS
247Spinal column injuryFAERS: 2US FAERS
248Tablet issueFAERS: 2US FAERS
249TachycardiaFAERS: 2US FAERS
250Upper respiratory tract congestionFAERS: 2US FAERS
251Urine output increasedFAERS: 2US FAERS
252Vascular occlusionFAERS: 2US FAERS
253Abdominal rigidityFAERS: 1US FAERS
254Abnormal sleep-related eventFAERS: 1US FAERS
255Accidental exposure to product by childFAERS: 1US FAERS
256Acute myocardial infarctionFAERS: 1US FAERS
257Alanine Aminotransferase IncreasedFAERS: 1US FAERS
258AlopeciaFAERS: 1US FAERS
259Amyotrophic Lateral SclerosisFAERS: 1US FAERS
260AngerFAERS: 1US FAERS
261Ankle FractureFAERS: 1US FAERS
262AnorexiaFAERS: 1US FAERS
263AnosmiaFAERS: 1US FAERS
264Arterial InjuryFAERS: 1US FAERS
265Arthropod biteFAERS: 1US FAERS
266Arthropod stingFAERS: 1US FAERS
267Auricular swellingFAERS: 1US FAERS
268Benign NeoplasmFAERS: 1US FAERS
269Biliary DyskinesiaFAERS: 1US FAERS
270Bipolar DisorderFAERS: 1US FAERS
271Bladder spasmFAERS: 1US FAERS
272Blood creatinine increasedFAERS: 1US FAERS
273Blood glucose decreasedFAERS: 1US FAERS
274Blood iron decreasedFAERS: 1US FAERS
275Blood pressure fluctuationFAERS: 1US FAERS
276Blood sodium decreasedFAERS: 1US FAERS
277Blood viscosity decreasedFAERS: 1US FAERS
278Bone painFAERS: 1US FAERS
279BradycardiaFAERS: 1US FAERS
280BronchiectasisFAERS: 1US FAERS
281BursitisFAERS: 1US FAERS
282Carpal Tunnel SyndromeFAERS: 1US FAERS
283Cerebral vasoconstrictionFAERS: 1US FAERS
284CholecystitisFAERS: 1US FAERS
285ChorioretinitisFAERS: 1US FAERS
286Chronic sinusitisFAERS: 1US FAERS
287ColitisFAERS: 1US FAERS
288Concomitant disease progressionFAERS: 1US FAERS
289ConjunctivitisFAERS: 1US FAERS
290Corrective lens userFAERS: 1US FAERS
291CystFAERS: 1US FAERS
292DeliriumFAERS: 1US FAERS
293Dental cariesFAERS: 1US FAERS
294DermatitisFAERS: 1US FAERS
295DiverticulitisFAERS: 1US FAERS
296Drug administered to patient of inappropriate ageFAERS: 1US FAERS
297Drug exposure via breast milkFAERS: 1US FAERS
298Drug screen false positiveFAERS: 1US FAERS
299DysarthriaFAERS: 1US FAERS
300DysphemiaFAERS: 1US FAERS
301DystoniaFAERS: 1US FAERS
302Ear discomfortFAERS: 1US FAERS
303Economic problemFAERS: 1US FAERS
304Elevated moodFAERS: 1US FAERS
305Emergency care examinationFAERS: 1US FAERS
306Epigastric discomfortFAERS: 1US FAERS
307Epstein-Barr virus antibody positiveFAERS: 1US FAERS
308Escherichia infectionFAERS: 1US FAERS
309Excessive eye blinkingFAERS: 1US FAERS
310Expired product administeredFAERS: 1US FAERS
311Exposure during breast feedingFAERS: 1US FAERS
312Eye irritationFAERS: 1US FAERS
313Facial PainFAERS: 1US FAERS
314Feeling of body temperature changeFAERS: 1US FAERS
315Feelings of worthlessnessFAERS: 1US FAERS
316Flank PainFAERS: 1US FAERS
317Food cravingFAERS: 1US FAERS
318Fracture painFAERS: 1US FAERS
319FractureFAERS: 1US FAERS
320Fungal test positiveFAERS: 1US FAERS
321GangreneFAERS: 1US FAERS
322Gastric mucosal lesionFAERS: 1US FAERS
323Gastroenteritis norovirusFAERS: 1US FAERS
324Gastrointestinal PainFAERS: 1US FAERS
325Heat ExhaustionFAERS: 1US FAERS
326HemiplegiaFAERS: 1US FAERS
327Hepatitis AFAERS: 1US FAERS
328Hepatitis BFAERS: 1US FAERS
329Hepatitis CFAERS: 1US FAERS
330HepatitisFAERS: 1US FAERS
331HepatomegalyFAERS: 1US FAERS
332House dust allergyFAERS: 1US FAERS
333HyperchlorhydriaFAERS: 1US FAERS
334HypersomniaFAERS: 1US FAERS
335Hypoaesthesia facialFAERS: 1US FAERS
336Hypocoagulable stateFAERS: 1US FAERS
337HypophagiaFAERS: 1US FAERS
338HyporeflexiaFAERS: 1US FAERS
339HypothyroidismFAERS: 1US FAERS
340ImmobileFAERS: 1US FAERS
341Impaired driving abilityFAERS: 1US FAERS
342IncoherentFAERS: 1US FAERS
343Infectious MononucleosisFAERS: 1US FAERS
344Intentional product use issueFAERS: 1US FAERS
345Intervertebral disc compressionFAERS: 1US FAERS
346Intervertebral disc injuryFAERS: 1US FAERS
347Intraspinal abscessFAERS: 1US FAERS
348Iron deficiencyFAERS: 1US FAERS
349Joint destructionFAERS: 1US FAERS
350LacerationFAERS: 1US FAERS
351Large intestine perforationFAERS: 1US FAERS
352LaryngitisFAERS: 1US FAERS
353Lichen PlanusFAERS: 1US FAERS
354Lip and/or oral cavity cancerFAERS: 1US FAERS
355Lipase decreasedFAERS: 1US FAERS
356Lower respiratory tract infectionFAERS: 1US FAERS
357Lymphocyte count decreasedFAERS: 1US FAERS
358Markedly reduced dietary intakeFAERS: 1US FAERS
359Mental RetardationFAERS: 1US FAERS
360MetastasisFAERS: 1US FAERS
361MetrorrhagiaFAERS: 1US FAERS
362Monocyte count increasedFAERS: 1US FAERS
363Multiple sclerosis relapseFAERS: 1US FAERS
364Musculoskeletal chest painFAERS: 1US FAERS
365MyoclonusFAERS: 1US FAERS
366Nasal discomfortFAERS: 1US FAERS
367NeuralgiaFAERS: 1US FAERS
368Neutrophil percentage increasedFAERS: 1US FAERS
369No adverse drug reactionFAERS: 1US FAERS
370NocturiaFAERS: 1US FAERS
371NoduleFAERS: 1US FAERS
372Obsessive-Compulsive DisorderFAERS: 1US FAERS
373Oropharyngeal swellingFAERS: 1US FAERS
374OtosclerosisFAERS: 1US FAERS
375Pain of skinFAERS: 1US FAERS
376Pancreatic carcinomaFAERS: 1US FAERS
377Paranasal sinus hypersecretionFAERS: 1US FAERS
378ParaparesisFAERS: 1US FAERS
379ParaplegiaFAERS: 1US FAERS
380Peptic Ulcer PerforationFAERS: 1US FAERS
381Peptic UlcerFAERS: 1US FAERS
382Peripheral swellingFAERS: 1US FAERS
383PhlebitisFAERS: 1US FAERS
384PneumothoraxFAERS: 1US FAERS
385PoliomyelitisFAERS: 1US FAERS
386PolymyositisFAERS: 1US FAERS
387Post-Traumatic Stress DisorderFAERS: 1US FAERS
388Prescribed overdoseFAERS: 1US FAERS
389Procedural complicationFAERS: 1US FAERS
390Product complaintFAERS: 1US FAERS
391Protein total increasedFAERS: 1US FAERS
392PsoriasisFAERS: 1US FAERS
393Pulmonary congestionFAERS: 1US FAERS
394PurpuraFAERS: 1US FAERS
395RegurgitationFAERS: 1US FAERS
396Respiratory tract congestionFAERS: 1US FAERS
397Restless Legs SyndromeFAERS: 1US FAERS
398RhinalgiaFAERS: 1US FAERS
399RhinitisFAERS: 1US FAERS
400Rotator cuff syndromeFAERS: 1US FAERS
401ScabFAERS: 1US FAERS
402SchizophreniaFAERS: 1US FAERS
403ScreamingFAERS: 1US FAERS
404Secretion dischargeFAERS: 1US FAERS
405Self-induced vomitingFAERS: 1US FAERS
406SepsisFAERS: 1US FAERS
407ShockFAERS: 1US FAERS
408Sinus TachycardiaFAERS: 1US FAERS
409Sinus painFAERS: 1US FAERS
410Sjogren's SyndromeFAERS: 1US FAERS
411Skin WrinklingFAERS: 1US FAERS
412Skin lacerationFAERS: 1US FAERS
413Skin lesionFAERS: 1US FAERS
414SluggishnessFAERS: 1US FAERS
415Spinal fusion surgeryFAERS: 1US FAERS
416SplenomegalyFAERS: 1US FAERS
417SpondylitisFAERS: 1US FAERS
418SpondylolisthesisFAERS: 1US FAERS
419StillbirthFAERS: 1US FAERS
420Synovial CystFAERS: 1US FAERS
421Tablet physical issueFAERS: 1US FAERS
422Tension HeadacheFAERS: 1US FAERS
423TensionFAERS: 1US FAERS
424Thyroid NeoplasmFAERS: 1US FAERS
425Tongue bitingFAERS: 1US FAERS
426Tooth ErosionFAERS: 1US FAERS
427Toxicity to various agentsFAERS: 1US FAERS
428Transmission of an infectious agent via a medicinal productFAERS: 1US FAERS
429Trigeminal NeuralgiaFAERS: 1US FAERS
430Troponin T increasedFAERS: 1US FAERS
431Unintentional use for unapproved indicationFAERS: 1US FAERS
432Unresponsive to stimuliFAERS: 1US FAERS
433Urinary IncontinenceFAERS: 1US FAERS
434Uterine CancerFAERS: 1US FAERS
435Vascular ruptureFAERS: 1US FAERS
436Vein painFAERS: 1US FAERS
437Venous InjuryFAERS: 1US FAERS
438Venous occlusionFAERS: 1US FAERS
439White blood cell count decreasedFAERS: 1US FAERS
440YawningFAERS: 1US FAERS
441colonoscopyFAERS: 1US FAERS
442furuncleFAERS: 1US FAERS
443muscle injuryFAERS: 1US FAERS
444Headache Disorders, Secondary11279966CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.